|
HS Code |
620771 |
| Chemical Name | 5-Bromo-2,4-Dichloro-6-Methylpyrimidine |
| Cas Number | 356783-16-9 |
| Molecular Formula | C5H2BrCl2N2 |
| Molecular Weight | 255.90 |
| Appearance | White to off-white solid |
| Solubility | Soluble in organic solvents such as dichloromethane |
| Purity | Typically ≥ 98% |
| Storage Temperature | Store at 2-8°C |
| Synonyms | 2,4-Dichloro-5-bromo-6-methylpyrimidine |
| Smiles | CC1=C(C(=NC(=N1)Cl)Br)Cl |
| Inchikey | RZHVJFTSOGUCHG-UHFFFAOYSA-N |
As an accredited 5-Bromo-2,4-Dichloro-6-Methylpyrimidine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 5-Bromo-2,4-Dichloro-6-Methylpyrimidine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Every experienced lab chemist understands how the right building block changes the trajectory of a synthetic route. 5-Bromo-2,4-Dichloro-6-Methylpyrimidine quickly stands out in this arena for its consistency and versatility. The structure, with the chemical formula C5H2BrCl2N2 and a molecular weight firmly in the 255 g/mol range, brings a combination of halogenation and methyl substitution that proves invaluable when exploring new chemical territory. While not uncommon to see halogenated pyrimidines in chemical catalogs, few marry this balance of reactivity and stability.
There’s a challenge shared among researchers: finding starting materials that push reactions forward without dragging in unnecessary complexity or cost. Tinkering in a synthetic organic lab for years, I’ve watched teams lose days—and sometimes weeks—when a core intermediate wasn’t quite up to par. Using 5-Bromo-2,4-Dichloro-6-Methylpyrimidine, setbacks rarely trace back to the compound itself. It forms the reliable backbone for producing pharmaceuticals, agricultural agents, and specialty dyes, whether you’re running small-batch experiments or exploring scale-up for industrial feeds.
Not all reactive intermediates provide the expected results. Those with delicate linkages or a tendency to break down under mild conditions slow progress and raise costs. What sets this pyrimidine derivative apart lies in its measured reactivity. The bromine and chloro substitutions activate the ring in specific positions, making it easier to control nucleophilic aromatic substitutions when needed, especially for downstream modifications in combinatorial libraries.
Over a decade of testing new synthetic routes has taught me that reaction reliability doesn’t come by chance. When sourcing 5-Bromo-2,4-Dichloro-6-Methylpyrimidine, batches tend to show strong purity—frequently exceeding 98% by HPLC or GC. This level of consistency ensures reactions start on solid footing, minimizing extra purification steps and the accompanying waste. The compound’s crystalline white to off-white appearance signals relative stability, and the melting point range, typically observed between 80°C and 90°C, fits well with the needs of stepwise temperature control in many synthetic settings.
Lab work rarely plays out under ideal conditions. Test tubes shatter, flasks boil over, storage space runs tight. Many pyrimidine derivatives impose strict requirements: inert gas protection, deep-freeze conditions, or rapid transfer protocols. In everyday use, 5-Bromo-2,4-Dichloro-6-Methylpyrimidine offers a breath of relief. At ambient temperature and humidity, it behaves without incident, showing little tendency to clump or degrade. This practical benefit often escapes product catalogs but makes all the difference in daily routine. You don’t lose valuable time protecting material from unnecessary environmental threats or watching for rapid decomposition.
The compound’s arrangement—a bromo group at position 5, chloro at positions 2 and 4, and a methyl anchor at position 6—not only affects basic reactivity but allows researchers to exploit steric and electronic factors often overlooked in more basic building blocks. Compared to its unsubstituted pyrimidine cousins, the increased molecular mass combined with multiple halogen atoms brings the opportunity for diverse downstream functionalization. It invites a greater variety of substitutions and cross-couplings, critically important for medicinal chemists pushing boundaries in heterocycle design.
This balance of electron-withdrawing chlorine and bromine atoms tempers the molecule’s reactivity. Attempts to substitute one group without disturbing another proceed with better selectivity, especially in hands familiar with transition metal catalysis or C–N bond formation. Such selectivity keeps yields high and purification smooth, which can tip the scales in favor of using this compound over others. This subtle gain matters on tight project schedules and budget-limited academic research.
In my own projects focused on early-stage pharmaceutical lead development, introducing 5-Bromo-2,4-Dichloro-6-Methylpyrimidine opened doors for optimizing kinase inhibitor scaffolds. The methyl group impacts how target molecules stack in protein active sites—a trait confirmed by both literature studies and my hands-on assays with enzyme panels. Many benchtop experiments aiming to modify at the 5-position benefit from the existing bromo group as a versatile handle for Suzuki or Sonogashira couplings. Other alternatives, such as mono-halogenated or unsubstituted pyrimidines, often require tedious extra steps or show less predictable reactivities.
Not just confined to drug discovery, this compound carved out space in fields as wide as agrochemical screening, fluorescent dye development, and advanced material design. Friends in the crop science field shared how the compound’s robust structure withstands formulation conditions where more fragile precursors falter. Others working on new luminescent materials noted its role as a precursor in modifying core electronic properties, allowing for tunable emission spectra without compromising yield.
Researchers always watch for downstream issues—especially environmental impact. Compared to more heavily fluorinated analogs, 5-Bromo-2,4-Dichloro-6-Methylpyrimidine avoids some of the long-term persistence in the environment associated with perfluorinated compounds, provided it’s handled responsibly in the laboratory and manufacturing floor. Disposal routines remain in line with typical halogenated lab waste, which reduces uncertainty both in budget planning and compliance checklists. This small difference shapes larger decisions about adopting a compound at scale.
Another overlooked benefit ties directly to the ability to diversify chemical libraries quickly. With its activated positions, chemists can access a broader range of derivatives in fewer steps—delivering timely answers to screening teams and supporting rapid lead optimization in fast-paced projects. Time and again, colleagues mention how “easy hits” with this compound’s scaffold shift programs from weeks to days.
Many commercially available pyrimidines lag behind in terms of both efficiency and breadth of application. Take 2,4-dichloropyrimidine, a staple for many, but limited by fewer points of manipulation and a less nuanced balance of electron density. The added methyl group in 5-Bromo-2,4-Dichloro-6-Methylpyrimidine doesn’t block synthetic potential; it steers it to more targeted results, growing diversity in final products with minimal synthetic baggage.
Base pyrimidines without halogenation show unpredictable reaction rates and over-oxidation in electrophilic reactions. Bromo and chloro modifications, as proven in routine labs, sharpen selectivity, offering cleaner profiles and superior purification handling. Rare is the compound that enhances both the journey and the destination. That’s the distinction here—fewer tedious cleanups, fewer column runs, and less solvent waste.
It’s easy to appreciate the small things after handling enough chemical headaches. Sensitive intermediates often gasp for stability or throw off byproducts that gum up subsequent steps. I’ve seen countless colleagues switch from lesser pyrimidines after encountering batch-to-batch issues—varying color, purity or spectral impurities that required rework. With this compound, the track record reflects routine shipment and satisfactory shelf life. It’s a relief not having to pause projects for an unexpected product failure. Old school chemists tell similar stories; new hires, too, quickly learn the frustration of subpar input materials and come to appreciate predictable consistency.
One must also mention the global move toward efficiency. Economic pressures in drug and agrichemical research mean every unnecessary step in a synthesis adds cost, waste, and uncertainty—sometimes even legal exposure around environmental regulation. In multi-step syntheses, reliable lead sources like 5-Bromo-2,4-Dichloro-6-Methylpyrimidine reduce the number of corrective maneuvers. This isn’t a glamorous point, but it cuts through the everyday fog of project management, freeing up brainpower for creative experimentation instead of fire-fighting avoidable mishaps.
Scientific honesty demands a level-headed perspective. Not every reaction benefits from starting with this compound. Certain highly nucleophilic substitutions bring competing side reactions, especially in media with trace water or acid. Beginners sometimes misjudge reaction temperatures, leading to decomposition. That said, each shortcoming presents a learning moment for teams willing to listen rather than barrel ahead. Safety protocols for halogenated intermediates require vigilance, mainly due to potential skin or respiratory irritation. Standard lab PPE and careful bench practice keep risks manageable.
From a scaling-up perspective, one must consider the cost and sourcing of specialty halogenated chemicals. Price fluctuations sometimes surface, and regulatory oversight increases for imports and exports, mainly with halogen content. Firms running near the regulatory margins check compliance records carefully and keep audit trails on file. These challenges aren’t unique to this compound but deserve attention before large-scale deployment, especially given today’s renewed scrutiny of chemical safety and regulatory adherence.
Waste handling occupies more of a lab manager’s mind than most admit. Halogenated byproducts need designated disposal containers and routine pickups. Careless waste handling undercuts the benefits gained upstream and raises costs unnecessarily. Teams that proactively track their waste output and work with trusted disposal partners keep operations smooth and defensible during periodic audits.
Some advances could streamline the use of this compound even further. Suppliers have begun offering more granular quality assurance data—batch certificates include impurity profiles with LC-MS and NMR, rather than relying on single-parameter checks like melting point. This aligns with a growing demand among researchers, regulatory agencies, and industry consortia for transparency and reproducibility. A better-informed buyer makes smarter, safer decisions, and the research as a whole benefits from fewer surprises.
From my time consulting for specialty chemical firms, I’ve watched new packaging designs reduce breakage in transit—double-lined containment for moisture exclusion, tamper-proof seals, and informative traceability codes. Small upgrades mean fewer supply hiccups, so research timelines become more predictable. Online ordering platforms now offer batch reserve and automated reordering, shrinking gaps between project planning and material arrival.
Green chemistry approaches offer a path forward, too. Development teams—especially those committed to sustainable lab management—have experimented with alternative solvents and milder conditions in reactions involving this compound. This shift, coupled with efforts to recycle halogenated byproducts, supports both regulatory compliance and corporate environmental responsibility.
Academic partnerships make another difference. Students and postdocs, as the natural explorers of new methods, can report side reactions or novel purification tricks to the wider chemical community. Journals and digital repositories have become more open to publishing these incremental yet vital findings, supporting an ecosystem of shared practical knowledge.
Over several decades of attending chemistry conferences and workshops, patterns become apparent. Large pharmaceutical outfits and nimble startups both lean on robust, well-characterized intermediates that allow fast, definitive progress. Anecdotal stories, which often travel faster than formal publications, highlight how 5-Bromo-2,4-Dichloro-6-Methylpyrimidine serves as a favored backbone when time and budget squeeze teams for rapid results.
At industrial scale, batch consistency becomes ever more crucial. Interruptions—due to a problematic synthetic intermediate or a shipment with purity issues—reverberate across departments, from analytical labs to production lines. Repeat buyers develop a routine relationship with suppliers, feeding back any problems or suggestions for improvement. Collective learning elevates the baseline for everyone.
Academic groups tend to focus on reactivity and structural tunability. They publish comparative studies: reaction times, yields, selectivity, and downstream transformation scope. Most journals report 5-Bromo-2,4-Dichloro-6-Methylpyrimidine as outperforming or equaling “gold standard” intermediates, especially in combinatorial applications and targeted substitution on the pyrimidine core.
Working with dozens of early-career chemists, I’ve seen how reliable, multifaceted intermediates steer project success. 5-Bromo-2,4-Dichloro-6-Methylpyrimidine, with its focused substitution pattern and strong chemical pedigree, accelerates pathfinding for both incremental and high-impact research. Its value lies not only in what it produces but also in the time and headaches it saves in the lab.
Colleagues in biotech and fine chemicals routinely express appreciation for intermediates that support scale-up without needing wholesale process redesigns. The supplier community hears this call and pushes for even narrower impurity windows and better batch documentation. Such market pressure encourages ongoing quality improvements, building a virtuous cycle for everyone relying on chemical building blocks that actually show up, work as claimed, and don’t mysteriously mutate in storage.
A look at industry purchasing data and patent filings confirms this compound's staying power. As research priorities shift—focusing on green chemistry, expedited process development, or more sophisticated therapeutic agents—the role of trustworthy intermediates becomes more central, not less. Researchers will keep reaching for this compound because it helps them solve genuine chemical problems, not because it’s the only option but because it’s often the best one for the job.
There’s something reassuring about a bottle of 5-Bromo-2,4-Dichloro-6-Methylpyrimidine tucked away in the stockroom. It means a project doesn’t have to stop for lack of a suitable starting point. The bottle, marked with a lot number and purity data, represents more than just grams of powder—it embodies trust built through years of trial and error, supplier negotiation, and shared problem-solving beyond the walls of any single lab.
The lessons learned using this compound carry forward: smart selection of initial materials begets smoother processes, and an eye for detail up front allows for bigger discoveries down the line. Research advances, both big and small, often trace back to reliable, well-understood chemical tools. For practical results in the unpredictable world of synthetic chemistry, 5-Bromo-2,4-Dichloro-6-Methylpyrimidine keeps earning its place on the shelf.